CN101181516B - Chinese medicine prescription orally taken for curing leukaemia - Google Patents
Chinese medicine prescription orally taken for curing leukaemia Download PDFInfo
- Publication number
- CN101181516B CN101181516B CN200710114338XA CN200710114338A CN101181516B CN 101181516 B CN101181516 B CN 101181516B CN 200710114338X A CN200710114338X A CN 200710114338XA CN 200710114338 A CN200710114338 A CN 200710114338A CN 101181516 B CN101181516 B CN 101181516B
- Authority
- CN
- China
- Prior art keywords
- grams
- curing
- leukaemia
- radix
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a Chinese traditional medicine formula for curing leukaemia by internall administration, which belongs to the field of Chinese traditional medicine. The Chinese traditional medicine formula for curing leukaemia through oral administration is made from the following materials: 20 grams of ginseng, 30 grams of radix astragali, 30 grams of sojutsu var, 25 grams of angelica, 15 grams of Tuckahoe, 15 grams of polygalae, 15 grams of fructus corni, 20 grams of siberian solomonseal rhizome, 30 grams of baihuashcshccao, 30 grams of scutellaria barbata, 3 grams of indigo and 10 grams of liquorice. The medicine is boiled with water, one dose and two times per day. By mixing the medicines, the invention can achieve synergistic effect; and by properly cooperating with Western medicine, the invention achieves significant effect in curing eukaemia.
Description
Technical field
The present invention relates to a kind of leukemic Chinese medicine preparation that is used for the treatment of for oral administration, belong to the field of Chinese medicines.
Background technology
Leukemia is a kind of malignant tumor of hemopoietic tissue.Its pathological characters is the paraplasm that a certain widely type korocyte is arranged in bone marrow and other hemopoietic tissue, this paraplasm leukocyte forfeiture normal function, and dysmaturity is arranged.The unusual performance of the type leukocyte amount and matter is arranged in blood, and extensively soak into body tissue and internal organs, cause the infringement of the structure and the function of this tissue and internal organs.The cause of disease has children that consanguineous marriage is given birth to more; Have chemicals, poisonous substance contact history; Contact for a long time with gasoline; Long-term contact hair dye; Useful forbidden drug treatment psoriasis, rheumatoid history; Long-term abuse slimming medicine; A large amount of finishing pollution gases that suck; Once be subjected to overshoot person.
Leukemia belongs to categories such as the traditional Chinese medical science " acute pulmonary tuberculosis ", " asthenia ", " epidemic febrile disease ", and disease is seen heating, and osteodynia is hemorrhage, anemia, hyperhidrosis etc.Chinese medicine has very big advantage aspect hemopathic treatment, and fully develop talents.Fundamentally pathogenic factor is removed outside body by methods such as Chinese medicine heat-clearing and toxic substances removing, dissipating phlegm and resolving masses, YIN nourishing removing heat from blood, made poison not have that institute gives birth to, evil nothing rises, its potential pathogenic factor disappearance, juvenile cell fades away, and disease is spontaneous remission also.
Summary of the invention
At the deficiency of present treatment, we by to over one hundred leukemic treatment in position, have found Chinese medicine for leukemic effect through the clinical practices of decades, have developed this kind and take orally and be used for the treatment of leukemic Chinese medicine preparation thereby sum up.
The present invention is achieved through the following technical solutions: this kind is for oral administration to be used for the treatment of leukemic Chinese medicine preparation, it is characterized in that, makes the raw materials of effective components medicine and by following weight is: Radix Ginseng 20 grams, the Radix Astragali 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Radix Angelicae Sinensis 25 grams, Poria 15 grams, Radix Polygalae 15 grams, Fructus Corni 15 grams, Rhizoma Polygonati 20 grams, Herba Hedyotidis Diffusae 30 grams, Herba Scutellariae Barbatae 30 grams, Indigo Naturalis 3 grams, Radix Glycyrrhizae 10 grams.
Usage: 1 dose of every day, decocting divides clothes 2 times.
Pharmacological action:
Radix Ginseng: strongly invigorating primordial QI, promote the production of body fluid admittedly take off, calm the nerves.It is deficient to control impairment caused by overstrain, lack of appetite, and asthenia, palpitation with fear, prolonged deficiency is not multiple, the card of all qi-blood-body fluid deficiencies.
The Radix Astragali: tonifying Qi and lifting yang, benefit are defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent.Cure mainly weakness of the spleen and stomach, lack of appetite asthenia, deficiency of vital energy blood prostration, exterior deficiency spontaneous perspiration, night sweat.
The Rhizoma Atractylodis Macrocephalae: spleen reinforcing, stomach reinforcing, dampness and in.Control deficient QI of the spleen and stomach, anorexia asthenia weak breath, deficiency-distension is had loose bowels, edema, jaundice, arthralgia chiefly caused by damp pathogen, dizziness, spontaneous perspiration.
Radix Angelicae Sinensis: benefiting blood and regulating blood circulation, menstruction regulating and pain relieving is moisturized laxation.Control menoxenia, amenorrhea stomachache; Headache due to deficiency of blood, dizzy; The carbuncle skin ulcer is stolen, injury from falling down.
Poria: eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Control dysuria, the edema distension, the phlegm retention cough with dyspnea, the sound of vomiting of vomitting is had loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful.
Radix Polygalae: the Fructus Alpiniae Oxyphyllae of calming the nerves, eliminate the phlegm resolving depression.Control palpitation with fear, forgetful, nocturnal emission, insomnia, cough ant phlegm, the carbuncle skin ulcer is swollen.
Fructus Corni: invigorating the liver and kidney, Gu arresting seminal emission gas is collapse.Control soreness of waist and knee joint, dizzy, tinnitus, sexual impotence, frequent micturition, the deficiency of the liver cold and heat, incessant sweating due to debility, the heart shakes scattered pulse.
Rhizoma Polygonati: invigorating the spleen and replenishing QI, profit cardiopulmonary, bone and muscle strengthening.Control deficient cold and heat, pulmonary tuberculosis hemoptysis, the empty lack of appetite of body after being ill, muscles and bones weakness, rheumatalgia, wind favus disease.
Herba Hedyotidis Diffusae: heat clearing away, dampness removing, detoxifcation.Control dyspnea and cough due to lung-heat, tonsillitis.
Herba Scutellariae Barbatae: heat clearing away, detoxifcation, dissipating blood stasis, hemostasis, analgesic therapy.Control haematemesis, epistaxis, stranguria with blood, bloody dysentery, lung abscess, cancerous protuberance, traumatic injury knife injury, venom.
Indigo Naturalis: heat clearing away, removing heat from blood, detoxifcation.Control the epidemic febrile disease intenseness of heat, macule is spitted blood, is spat blood, and skin ulcer is swollen, erysipelas, snake bite and insect sting.
Radix Glycyrrhizae: and middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription. control laryngopharynx swelling and pain, peptic ulcer, ulcer sores is separated poison of drug and alimentary toxicosis.
After the present invention mixed said medicine, its drug effect synergism suitably cooperated Western medicine to obtain remarkable result in leukemic therapeutic process.Now will adopt medicine of the present invention and other Western medicine, the clinical effectiveness of therapy of combining Chinese and Western medicine acute and chronic leukemia 80 examples is described as follows:
1, physical data: acute leukemia 36 examples wherein, chronic leukemia 44 examples, male's 40 examples, women's 40 examples, age 3-68 year sees that all cases are all through my centring system treatment.Acute leukemia complete remission rate 88%, part remission rate 6%, mortality rate 6% (dying from complication) more, 3 years existence follow-up rate existence in 86%, 5 year follow-up rate existence in 47%, 10 year follow-up rate 20%, chronic leukemia (slow grain, pouring slowly), complete remission rate 96%, invalid 4%.5 years existence follow-up rate existence in 89%, 10 year follow-up rate existence in 52%, 15 year follow-up rate 26%.
2, Therapeutic Method: adopt the Chinese and Western combination,, cooperate the new technique of navel blood stem cell infusion based on the traditional Chinese medical science, new therapy, instant effect, short treating period, expense is low, and side effect is little.
3, the course of treatment: acute leukemia, acute stages treated 3-6 month, after treatment 6-12 month.Chronic leukemia, early treatment 3-6 month, after treatment 12-18 month.
4, curative effect: acute leukemia, can eliminate symptom, alleviate fully, long term survival, general 5-10, life and work is normal.Chronic leukemia can be eliminated symptom, the general 10-20 of normal existence.
Attached model case:
Example one: high certain, man, 46 years old, people from Hunan, the peasant, in February, 1999 morbidity, check through the attached institute of Hunan medical college to be diagnosed as: acute nonlymphocytic leukemia M5a, after change my institute treating hematopathy center over to, surplus through controlling August, alleviation is gone home, again by diagnosis by correspondence after treatment drug withdrawal in a year.Now work, live that all are normal, came my center check once more on April 22nd, 2002, Hb:154g/L, WBC:5.4 * 109/L, BPC:118 * 109/L, bone is worn inspection, and normal marrow resembles, now normal existence 5 years.
Example two: the Wang, the man, 56 years old, people from Shandong, the cadre, morbidity at the beginning of 1992, how tame hospital is diagnosed as: chronic myelocytic leukemia, once sought medical advice everywhere, after my department's system Comprehensive Treatment, the state of an illness is alleviated, now normal disease free survival 15 years.
Example three: in certain, the woman, 18 years old, people from Sichuan, acute lymphoblastic leukemia, SH May in 1997 was alleviated, after adhered to the outpatient service after treatment 2 years, existing anosis normal existence.
The specific embodiment
Example one: a kind of taking orally is used for the treatment of leukemic Chinese medicine preparation, makes the raw materials of effective components medicine and by following weight is: Radix Ginseng 20 grams, the Radix Astragali 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Radix Angelicae Sinensis 25 grams, Poria 15 grams, Radix Polygalae 15 grams, Fructus Corni 15 grams, Rhizoma Polygonati 20 grams, Herba Hedyotidis Diffusae 30 grams, Herba Scutellariae Barbatae 30 grams, Indigo Naturalis 3 grams, Radix Glycyrrhizae 10 grams.
Usage: 1 dose of every day, decocting divides clothes 2 times.
Claims (1)
1. one kind for oral administration is used for the treatment of leukemic Chinese medicine, it is characterized in that, makes the raw materials of effective components medicine and by following weight is: Radix Ginseng 20 grams, the Radix Astragali 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Radix Angelicae Sinensis 25 grams, Poria 15 grams, Radix Polygalae 15 grams, Fructus Corni 15 grams, Rhizoma Polygonati 20 grams, Herba Hedyotidis Diffusae 30 grams, Herba Scutellariae Barbatae 30 grams, Indigo Naturalis 3 grams, Radix Glycyrrhizae 10 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710114338XA CN101181516B (en) | 2007-11-15 | 2007-11-15 | Chinese medicine prescription orally taken for curing leukaemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710114338XA CN101181516B (en) | 2007-11-15 | 2007-11-15 | Chinese medicine prescription orally taken for curing leukaemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101181516A CN101181516A (en) | 2008-05-21 |
| CN101181516B true CN101181516B (en) | 2011-03-16 |
Family
ID=39447028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710114338XA Expired - Fee Related CN101181516B (en) | 2007-11-15 | 2007-11-15 | Chinese medicine prescription orally taken for curing leukaemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101181516B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107007743A (en) * | 2017-03-31 | 2017-08-04 | 天津市善济宏兴科技发展有限公司 | For treating the qi-blood deficiency leukemogenic compound Chinese medicinal preparation of institute and preparation method |
| CN106822764A (en) * | 2017-03-31 | 2017-06-13 | 天津市善济宏兴科技发展有限公司 | For treating the leukemogenic compound Chinese medicinal preparation of deficiency of spleen-QI and stomach-QI institute and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390588A (en) * | 2002-08-06 | 2003-01-15 | 王凯 | Composite medicine for treating leukemia |
| CN1879841A (en) * | 2006-05-17 | 2006-12-20 | 郭富红 | A Chinese medicine for treating leukemia |
-
2007
- 2007-11-15 CN CN200710114338XA patent/CN101181516B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390588A (en) * | 2002-08-06 | 2003-01-15 | 王凯 | Composite medicine for treating leukemia |
| CN1879841A (en) * | 2006-05-17 | 2006-12-20 | 郭富红 | A Chinese medicine for treating leukemia |
Non-Patent Citations (4)
| Title |
|---|
| 康永等.中医药治疗白血病临床点滴.河北中西医结合杂志8 3.1999,8(3),419-420. |
| 康永等.中医药治疗白血病临床点滴.河北中西医结合杂志8 3.1999,8(3),419-420. * |
| 康永等.辨证治疗白血病24例临床体会.中国中医药信息杂志6 7.1999,6(7),68. |
| 康永等.辨证治疗白血病24例临床体会.中国中医药信息杂志6 7.1999,6(7),68. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101181516A (en) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703730B (en) | Health care wine made of ginseng and the like | |
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN102274361A (en) | Anticancer medicinal composition and preparation method of decoction thereof | |
| CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
| CN104383390A (en) | Chinese traditional medicine preparation for treating lung cancer | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN102357211B (en) | Traditional Chinese medicine composition for curing cancers | |
| CN104069466A (en) | Traditional Chinese medicament for treating uremia | |
| CN1233483A (en) | Traditional Chinese medicine for treating cirrhosis and liver cancer | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN101804155B (en) | Medicine used for treating qi and blood deficiency caused by radiotherapy and chemotherapy of tumor and postoperative body weakness, and preparation method thereof | |
| CN1049827C (en) | Anti-cancer powder | |
| CN101181516B (en) | Chinese medicine prescription orally taken for curing leukaemia | |
| CN101912596A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN102078559A (en) | Chinese medicinal composition with functions of tonifying kidney and strengthening brain | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN102028890B (en) | Traditional Chinese medicine composition for treating uremia | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN101703660B (en) | Anti-aging medicament | |
| CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
| CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
| CN104547553A (en) | Traditional Chinese medicine for treating nervous endocrine disorder | |
| CN104888136A (en) | Traditional Chinese medicine composition for treatment of insomnia | |
| CN105267630A (en) | Traditional Chinese medicine for treating tinnitus | |
| CN101444616B (en) | Medicated wine for curing chronic rheumatism and method for preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG CHUNXIU Free format text: FORMER OWNER: WANG YUXIN Effective date: 20101217 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250200 NO. 65, QINGZHAO ROAD, ZHANGQIU CITY, JI NAN CITY, SHANDONG PROVINCETO: 252000 PEDIATRIC SECTION II, LIAOCHENG SECOND PEOPLE S HOSPITAL, NO. 306, JIANKANG STREET, LINQING CITY, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20101217 Address after: 252000 two children's Hospital, Liaocheng Second People's Hospital, 306 health Street, Linqing, Shandong Applicant after: Zhang Chunxiu Address before: Zhangqiu City, Ji'nan City, Shandong province 250200 kiyoteru Road No. 65 Applicant before: Wang Yuxin |
|
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Chunxiu Inventor before: Wang Yuxin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG YUXIN TO: ZHANG CHUNXIU |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110316 Termination date: 20111115 |